Seeking Alpha

  Geron Corporation - NASDAQ

11/1/2014, 7:55 AM ET
  • Life Sciences Report | Send Message 8 May

    Live Longer, Get Richer With Patrick Cox $GERN, $BTX
      GERN vs. ETF Alternatives
      Company Description
      Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States